ASCO

ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
This Week in Biotech: A Trifecta of Disappointment Mars ASCO While Biogen Scores a Big Victory
Motley Fool
Mon, 06/9/14 - 09:17 am
ASCO
Biogen Idec
Elocate
neratinib
Puma Biotechnology
CO-1686
Clovis Oncology
Tykerb
GSK
Roche
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Yahoo/Benzinga
Thu, 06/5/14 - 12:04 pm
ASCO
cancer immunotherapy
Bristol-Myers Squibb
Yervoy
Merck
MK-3475
ASCO: Bristol-Myers Squibb and Merck Don't Disappoint
Motley Fool
Thu, 06/5/14 - 11:17 am
ASCO
Merck
Bristol-Myers Squibb
anti-PD-1 immunotherapy
MK-3475
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
Yahoo/Benzinga
Thu, 06/5/14 - 09:14 am
ASCO
Pfizer
Aromasin
tamoxifen
DARA Biosciences
breast cancer
Herceptin
Tykerb
GSK
Eli Lilly
Bristol-Myers Squibb
Erbitux
ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
Yahoo/Benzinga
Wed, 06/4/14 - 03:20 pm
ASCO
cancer
Imbruvica
JNJ
Eli Lilly
Cyramza
ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects
Yahoo/Benzinga
Wed, 06/4/14 - 03:18 pm
Fertility
cancer
ASCO
Zoladex
AstraZeneca
Novartis
Zometa
Incyte Gains on Positive Jakafi Data
Yahoo/Zacks.com
Wed, 06/4/14 - 02:53 pm
Incyte
Jakafi
polycythemia vera
ASCO
AstraZeneca fights to regain cancer market prominence
Yahoo/Reuters
Wed, 06/4/14 - 09:26 am
AstraZeneca
Pfizer
ASCO
[video]Clovis CEO: We can win against AstraZeneca
CNBC
Tue, 06/3/14 - 02:23 pm
AstraZeneca
Clovis Oncology
ASCO
CO-1686
lung cancer
AZD9291
ASCO 2014: Doubling Down on Next-Gen Cancer Drugs
Motley Fool
Tue, 06/3/14 - 12:26 pm
ASCO
Roche
Amgen
blinatumomab
AstraZeneca
cancer
biospecific antibodies
Cancer drug data supports advanced trials - AstraZeneca
Yahoo/Reuters
Tue, 06/3/14 - 12:24 pm
AstraZeneca
ASCO
cancer
MEDI4736
Eli Lilly reports CYRAMZA significantly improves survival in Phase 3 study
Yahoo/Fly on the Wall
Tue, 06/3/14 - 09:58 am
Cyramza
Eli Lilly
ASCO
non-small cell lung cancer
Incyte's 'IDO' Cancer Immunotherapy Causes Investor Scrum at ASCO '14
TheStreet.com
Mon, 06/2/14 - 06:09 pm
Incyte
ASCO
immunotherapy
melanoma
INCB024360
GTx reports results from Phase 2 study of enobosarm
Yahoo/Fly on the Wall
Mon, 06/2/14 - 02:58 pm
GTx
enobosarm
breast cancer
metastatic breast cancer
ASCO
Celldex says Varlilumab continues to demonstrate very favorable profile
Yahoo/Fly on the Wall
Mon, 06/2/14 - 02:55 pm
Celldex Therapeutics
varlilumab
cancer
ASCO
Bristol Defends Data; Roche Shines In Cancer Showdown
Investors.com
Mon, 06/2/14 - 02:51 pm
Roche
Bristol-Myers Squibb
nivolumab
Yervoy
melanoma
MPDL3280A
bladder cancer
ASCO
Sunesis says encouraged by trial of Qinprezo
The Fly on the Wall
Mon, 06/2/14 - 11:07 am
Qinprexo
Sunesis
ASCO
acute myeloid leukemia
myelodysplastic syndrome
ADXS: What Does the J&J Deal with Aduro Mean for Advaxis?
Yahoo/Zacks.com
Mon, 06/2/14 - 11:04 am
JNJ
Aduro BioTech
Advaxis
Janssen Biotech
prostate cancer
ASCO
Merck Immunotherapy Posts Striking Results Against Advanced Melanoma
TheStreet.com
Mon, 06/2/14 - 10:42 am
Merck
melanoma
ASCO
MK-3475

Pages